BRANDI CRAWFORD: Open Payments
NPI 1790939684 · ASHLAND, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 44 payments from 15 companies in 2025. Trend: 2023 $601 · 2024 $574 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $388 |
| PFIZER INC. | 4 | $90 |
| ABBVIE INC. | 4 | $74 |
| Amgen Inc. | 4 | $68 |
| Exact Sciences Corporation | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: Ozempic, Wegovy, ELIQUIS, Cologuard Collection Kit, OTEZLA, Kerendia, Rybelsus, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
